Aeterna Zentaris Abstract Accepted for Presentation at : vim

– Company advancing development of its Autoimmunity Modifying AIM Biologicals as a potential therapeutic treatment option for Parkinson’s Disease ("PD"), a...

Related Keywords

United States , Portland , Oregon , Toronto , Ontario , Canada , Oregon Convention Center , American , Chi Wang Ip , Joerg Wischhusen , Klaus Paulini , Valentin Bruttel , Event Of The American Association Immunologists , School Of Medicine , Department Of Obstetrics , Aeterna Zentaris , Department Of Neurology , Nasdaq , University Of Wuerzburg The , Aeterna Zentaris Inc , Autoimmunity Modifying , Annual Event , American Association , Experimental Tumor Immunology , Therapeutic Approaches , Based Therapeutics , Chief Executive Officer , Nasdaq Aezs , Tsezs , Mmunology2022 , Im Biologicals , Diagnostic Products , Parkinsons Disease , Iopharmaceutical , Medicine ,